Xtant Medical Holdings, Inc. announced that it purchased the product lines of Coflex and Cofix from Surgalign Holdings, Inc. for $17 million. The deal closed on February 28, 2023.
UBS Investment Bank served as the exclusive financial advisor and DLA Piper LLP served as legal counsel to Surgalign. Fox Rothschild LLP served as legal counsel to Xtant.
Coflex is an interlaminar stabilization device used after an open decompression that can be performed in various settings, offering a non-fusion treatment option for lumbar spinal stenosis patients. Cofix is a supplemental fixation device, which is a minimally invasive system intended for use on all levels of the lumbar spine.
Xtant Medical is a global medical technology company focused on the design, development and commercialization of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Third quarter 2022 revenue was $14.5 million.
Surgalign Holdings, Inc. is a global medical technology company that uses digital health to transform the surgical landscape.
According to data captured in the LevinPro HC database, this acquisition represents the 26th Medical Devices transaction of the year.
